The average price per share was RON0.27 and the cumulated value of transaction reached RON3.091 million.
SIF Banat-Crisana decided to further buy Biofarm shares after the Romanian state, through the privatization authority AAAS, put Biofarm shares up for sale. Consequently, the fund boosted its exposure, owning over 23% of Biofarm shares, which is the second biggest participation in the company, after the stake held by majority shareholder SIF Muntenia (SIF4.RO), which owns 50.98% of Biofarm shares.
Biofarm’s market capitalization reaches RON266 million (EUR59.64 million), after the value of one Biofarm share has decreased by 4.26% since the beginning of 2016.
Biofarm reported sales revenue of RON69.2 million in the first half of 2016, down 1% from the same period in 2015. Its profit reached RON15.2 million in January-June 2016, up 1% from the year-earlier period.
In 2015, Biofarm reported total revenue of RON152.8 million, up over 8% against 2014.